Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EXEnatide in Patients Undergoing Coronary Artery Bypass Grafting for Improved glUcose conTrol and hemodynamIc ValuEs

NCT01373216 is registered in ClinicalTrials.gov with Charles University, Czech Republic as lead sponsor.

NCT NCT01373216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01373216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EXEnatide in Patients Undergoing Coronary Artery Bypass Grafting for Improved glUcose conTrol and hemodynamIc ValuEs
Lead sponsor
Charles University, Czech Republic
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2011
Completion date
December 31, 2014
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, decreased left ventricular function